logo True scholar network
Back to Top
Visit Website

Pediatric Hematology and Oncology (PHO)

Publisher :

Taylor & Francis

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • PHO: Pediatric Hematology and Oncology
  • Treatment in diverse clinical settings
  • Novel insights into pathogenesis and/or clinical care

    • +4

e-ISSN :

1521-0669

Issue Frequency :

8-issues-year

Impact Factor :

1.2

p-ISSN :

0888-0018

Est. Year :

2025

Mobile :

4402080520500

DOI :

YES

Country :

India

Language :

English

APC :

YES

Impact Factor Assignee :

google scholar

Email :

enquiries@taylorandfrancis.com

Journal Descriptions

PHO: Pediatric Hematology and Oncology is an international journal covering all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood. The journal’s goal is to make PHO: Pediatric Hematology and Oncology the premier journal for the international community of clinicians, scientists, hematologists, oncologists, and other healthcare professions who together aim to define optimal therapeutic strategies for children and young adults with cancer and blood disorders. The journal is interested in basic, clinical, and translational research. Topics of interest include, but are not limited to: Treatment in diverse clinical settings Novel insights into pathogenesis and/or clinical care Genetics Molecular diagnostics and targeting Pharmacology Stem cells Cellular and immune therapies Transplantations Supportive care Ethical, legal, psychological, social, cultural, or historical aspects of the field The journal publishes the following article types Original Research Articles Review Articles Letters to the Editor Brief Reports Meeting Proceedings


Pediatric Hematology and Oncology (PHO) is :

International, Peer-Reviewed, Open Access, Refereed, PHO: Pediatric Hematology and Oncology, Treatment in diverse clinical settings, Novel insights into pathogenesis and/or clinical care, Pharmacology, Stem cells, Original Research Articles, Transplantations , Online or Print, 8-issues-year Journal

UGC Approved, ISSN Approved: P-ISSN - 0888-0018, E-ISSN - 1521-0669, Established in - 2025, Impact Factor - 1.2

Provide Crossref DOI

Indexed in Scopus, WoS

Not indexed in DOAJ, PubMed, UGC CARE

Indexing

Scopus Profile
Scopus
Scopus Profile
WoS
Scopus Profile
Crossref

+1 More

Publications of PHO

  • dott image June, 2025

Safety and Tolerability of a 3-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients: Results...

Convenient multiday dosing of antiemetic regimens for the prevention of chemotherapy-induced nausea and vomiting (CINV) are needed in pediatric patients, who are more likely than adults to b...

  • dott image September, 2025

The relationship between circulating tumor cells in peripheral blood and clinical characteristics of pediatric neuroblastoma and prognostic evaluation

This study investigates the correlation between circulating tumor cells (CTCs) in peripheral blood and the clinical characteristics and prognosis of advanced pediatric neuroblastoma (NB). We...

  • dott image September, 2025

Iron deficiency anemia among infants: a retrospective cohort study

Postnatal iron deficiency, especially from ages 6 to 24 months, has long-term consequences lasting into adolescence and adulthood. We aimed to characterize iron deficiency anemia among inf...

  • dott image September, 2025

Impact of regional SARS-CoV-2 proceedings on changes in diagnoses of pediatric malignancies in Bavaria during the COVID-19 pandemic

The COVID-19 pandemic affected daily life significantly and had massive consequences for healthcare systems with tremendous regional differences. This retrospective study aimed to investigat...

  • dott image June, 2024

Hospital acquired venous thromboembolism in children with sickle cell disease

Sickle cell disease (SCD) is well recognized as a hypercoagulablestate, however, it remains unclear whether a subgroup of children with SCD at higher risk of venous thromboembolic event (VTE...

  • dott image April, 2024

Therapeutic efficacy of RAS inhibitor trametinib using a juvenile myelomonocytic leukemia patient-derived xenograft model

Juvenile myelomonocytic leukemia (JMML) is an aggressive pediatric leukemia with few effective treatments and poor outcomes even after stem cell transplantation, the only current curative tr...

  • dott image February, 2024

The significance of surveillance imaging in children with Ewing sarcoma and osteosarcoma

Primary bone tumors in children and adolescents, while rare, pose significant challenges in diagnosis and management. Children treated for Ewing sarcoma and osteosarcoma are offered a 5-year...

  • dott image October, 2023

Access to Methotrexate Monitoring in Latin America: A Multicountry Survey of Supportive Care Capacity

High-dose methotrexate (HDMTX) is used to treat a broad spectrum of cancers. Methotrexate (MTX) monitoring and adequate supportive care are critical for safe drug administration; however, MT...

  • dott image June, 2023

Consensus survey on the management of children with chemotherapy-induced febrile neutropenia and at low risk of severe infection

Our aim was to identify national consensus criteria for the management of children with chemotherapy-induced febrile neutropenia (FN), for evidence-based step-down treatment approaches for p...

  • dott image February, 2023

Multicenter real-world experience of the clinical efficacy and tolerance of pazopanib in high-risk pediatric solid tumors (PazoPed)

Multicenter real-world experience of the clinical efficacy and tolerance of pazopanib in high-risk pediatric solid tumors (PazoPed)

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile